
-
Russian missile strike kills 14 in Ukraine leader's home city
-
Trump's tariff Big Bang puts global economy under threat
-
I Am Maximus backed for National as Mullins hot streak continues
-
2014 World Cup winner Hummels to retire at season's end
-
Intercommunal violence kills dozens in central Nigeria
-
Nigerian, S. African music saw 'extraordinary growth' in 2024: Spotify
-
Russell Brand: From Hollywood star to rape suspect
-
France soccer star Mbappe unveiled in London... in waxwork form
-
Trump goads China as global trade war escalates
-
Israel expands Gaza ground offensive, hits Hamas in Lebanon
-
TikTok faces new US deadline to ditch Chinese owner
-
US Fed Chair warns tariffs will likely raise inflation, cool growth
-
Mbappe among three Real Madrid players fined for 'indecent conduct'
-
How can the EU respond to Trump tariffs?
-
Canada loses jobs for first time in 3 years as US tariffs bite
-
Real Madrid and Barcelona respect each other, says Ancelotti
-
Nations divided ahead of decisive week for shipping emissions
-
Trump goads China after Beijing retaliates in global trade war
-
Arteta urges Arsenal to enjoy "beautiful" run-in despite injury woes
-
London mayor gets new powers to revive capital's ailing nightlife
-
Italy's ski star Brignone takes on 'new challenge' after serious leg injury
-
Amorim in a 'rush' to succeed at Man Utd
-
PSG coach Luis Enrique targets unbeaten season
-
Duterte victims seeking 'truth and justice': lawyer
-
US job growth strong in March but Trump tariff impact still to come
-
UK comedian and actor Russell Brand charged with rape
-
Stocks, oil slump as China retaliates and Trump digs in heels
-
Postecoglou 'falling out of love' with football due to VAR
-
EU hails 'new era' in relations with Central Asia
-
US hiring beats expectations in March as tariff uncertainty brews
-
'Unique' De Bruyne one of the greats, says Guardiola
-
Automakers shift gears after Trump tariffs
-
Where things stand in the US-China trade war
-
De Bruyne to leave Man City at end of the season
-
Youthful Matildas provide spark in friendly win over South Korea
-
Stocks, oil extend rout as China retaliates over Trump tariffs
-
De Bruyne says he will leave Man City at end of season
-
UK spy agency MI5 reveals fruity secrets in new show
-
Leverkusen's Wirtz to return 'next week', says Alonso
-
England bowler Stone to miss most of India Test series
-
Taiwan earmarks $2.7 bn to help industries hit by US tariffs
-
Rat earns world record for sniffing landmines in Cambodia
-
Elton John says new album 'freshest' since 1970s
-
EU announces 'new era' in relations with Central Asia
-
Greece nixes Acropolis shoot for 'Poor Things' director
-
'Historic moment': South Koreans react to Yoon's dismissal
-
Israel kills Hamas commander in Lebanon strike
-
Trump unveils first $5 million 'gold card' visa
-
Crashes, fires as Piastri fastest in chaotic second Japan GP practice
-
India and Bangladesh leaders meet for first time since revolution
RBGPF | 1.48% | 69.02 | $ | |
CMSC | -0.54% | 22.14 | $ | |
SCS | -1.13% | 10.62 | $ | |
NGG | -4.28% | 66.54 | $ | |
AZN | -6.68% | 69.29 | $ | |
RIO | -6.68% | 54.77 | $ | |
GSK | -6.12% | 36.76 | $ | |
RELX | -4.62% | 49.17 | $ | |
RYCEF | -16.39% | 8.42 | $ | |
BP | -9.29% | 28.675 | $ | |
JRI | -6.94% | 11.988 | $ | |
BCC | 0.23% | 94.85 | $ | |
CMSD | -0.09% | 22.65 | $ | |
BCE | 1.09% | 22.91 | $ | |
VOD | -9.72% | 8.54 | $ | |
BTI | -4.25% | 40.21 | $ |

Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
M.Fischer--AMWN